Switching Language

Please note that your current login session is only valid on the English site (letpub.com). You will not be signed in on other language versions of the site. If you wish to place an order, please return to the English site.

    Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector


New Free Tool: Verity — Pre-Submission Manuscript Check
Automatically checks your manuscript across 34 criteria including structure, metadata, disclosures, and language issues before you submit to your target journal.
Try for Free →
  
  
-

EXPERT OPINION ON EMERGING DRUGS


👁  9950 Views

 6 Reviews  

 Open Access      SCIE      Official Website     Submission Website
 

*Average Peer Review
>12 Week(s), or Invited contributions
*Competitiveness
Moderate
CiteScore
4.7
CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Pharmacology (medical)		 105 / 275
Category: Medicine
Subcategory: Pharmacology		 151 / 321
Link to PubMed Central (PMC)
https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1472-8214%5BISSN%5D

Indexing (SCI collection)
Science Citation Index Expanded (SCIE)
Scopus (CiteScore)

Country/Area of Publication
ENGLAND
Publication Frequency
Quarterly
Publisher
Taylor and Francis Ltd.

ISSN
1472-8214
E-ISSN
1744-7623
Year Publication Started
2001

Self-citation (2024-2025)
0.00%
Annual Article Volume
28
Gold OA Percentage
7.23%

Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A
Journal Aim & Scope
Expert Opinion on Emerging Drugs (ISSN 1472-8214 [print], 1744-7623 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing structured reviews on Phase II and Phase III drugs/drug classes emerging onto the market across all therapy areas, providing expert opinion on their potential impact on the current management of specific diseases.

Web of Science Quartiles
WOS Quartile: Q2

Quartiles By JIFCollectionQuartileRankPercentage
Category: PHARMACOLOGY & PHARMACYSCIEQ2164/352
Quartiles By JCICollectionQuartileRankPercentage
Category: PHARMACOLOGY & PHARMACYSCIEQ4270/353
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    DRUG RESISTANCE UPDATES10023.20
    TRENDS IN PHARMACOLOGICAL SCIENCES20125.70
    ADVANCED DRUG DELIVERY REVIEWS27836.00
    PHARMACOLOGICAL REVIEWS21034.00
    PHARMACOLOGY & THERAPEUTICS18026.20
    MEDICINAL RESEARCH REVIEWS11929.50
    PHARMACOLOGICAL RESEARCH11818.60
    PHYTOMEDICINE10511.60
    DRUG DELIVERY5216.40
    BRITISH JOURNAL OF PHARMACOLOGY19014.40
  • EXPERT OPINION ON EMERGING DRUGS EXPERT OPINION ON EMERGING DRUGS
    Predict CiteScore Trend：
    Steady Increase No Change Gradual Decline　 Refresh
 
    👁  9950 Views
    ☰  Reviews        
 
 
 

Select your rating and start your review of EXPERT OPINION ON EMERGING DRUGS

 

    Journals In The Same Field
    CA-A CANCER JOURNAL FOR CLINICIANS
    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERY
    CiteScore: 181.80
    MMWR Recommendations and Reports
    CiteScore: 129.90
    Nature Reviews Clinical Oncology
    CiteScore: 114.50
    Nature Reviews Disease Primers
    CiteScore: 113.30
    NATURE REVIEWS CANCER
    CiteScore: 103.80
    NEW ENGLAND JOURNAL OF MEDICINE
    CiteScore: 96.40
    LANCET
    CiteScore: 87.60
    NATURE REVIEWS IMMUNOLOGY
    CiteScore: 84.70
    NATURE MEDICINE
    CiteScore: 82.40



    © 2010-2026  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
    Privacy • Terms of Servic